UniPharma is currently owned by founding shareholders and a private equity fund managed by , the largest independent asset manager in Saudi Arabia and one of the leading private equity investors in the Middle East.

Following Jadwa’s investment for a 51% share ownership in the Group, UniPharma has further strengthened its corporate governance, including the addition of independent Board members, Board committees, and an Internal Audit function.

As UniPharma invites additional investors on its growth journey, we will share more information for existing and prospective investors on this page.